In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry
- PMID: 17601776
- PMCID: PMC1913863
- DOI: 10.1073/pnas.0703875104
In vivo quantitation of rare circulating tumor cells by multiphoton intravital flow cytometry
Abstract
Quantitation of circulating tumor cells (CTCs) constitutes an emerging tool for the diagnosis and staging of cancer, assessment of response to therapy, and evaluation of residual disease after surgery. Unfortunately, no existing technology has the sensitivity to measure the low numbers of tumor cells (<1 CTC per ml of whole blood) that characterize minimal levels of disease. We present a method, intravital flow cytometry, that noninvasively counts rare CTCs in vivo as they flow through the peripheral vasculature. The method involves i.v. injection of a tumor-specific fluorescent ligand followed by multiphoton fluorescence imaging of superficial blood vessels to quantitate the flowing CTCs. Studies in mice with metastatic tumors demonstrate that CTCs can be quantitated weeks before metastatic disease is detected by other means. Analysis of whole blood samples from cancer patients further establishes that human CTCs can be selectively labeled and quantitated when present at approximately 2 CTCs per ml, opening opportunities for earlier assessment of metastatic disease.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands.Int J Cancer. 2008 Oct 15;123(8):1968-73. doi: 10.1002/ijc.23717. Int J Cancer. 2008. PMID: 18661519 Free PMC article.
-
Real-time monitoring of rare circulating hepatocellular carcinoma cells in an orthotopic model by in vivo flow cytometry assesses resection on metastasis.Cancer Res. 2012 May 15;72(10):2683-91. doi: 10.1158/0008-5472.CAN-11-3733. Epub 2012 Mar 26. Cancer Res. 2012. PMID: 22454286
-
Real-time in vivo imaging of subpopulations of circulating tumor cells using antibody conjugated quantum dots.J Nanobiotechnology. 2019 Feb 6;17(1):26. doi: 10.1186/s12951-019-0453-7. J Nanobiotechnology. 2019. PMID: 30728024 Free PMC article.
-
Multiphoton flow cytometry strategies and applications.Cytometry A. 2011 Oct;79(10):775-88. doi: 10.1002/cyto.a.21110. Epub 2011 Jul 27. Cytometry A. 2011. PMID: 21796772 Review.
-
[Circulating tumor cells (CTCs)--clinical significance in patients with ovarian cancer].Ginekol Pol. 2012 Apr;83(4):291-4. Ginekol Pol. 2012. PMID: 22712262 Review. Polish.
Cited by
-
Prognostic impact of detecting viable circulating tumour cells in gastric cancer patients using a telomerase-specific viral agent: a prospective study.BMC Cancer. 2012 Aug 9;12:346. doi: 10.1186/1471-2407-12-346. BMC Cancer. 2012. PMID: 22873704 Free PMC article.
-
Efficient capture of circulating tumor cells with low molecular weight folate receptor-specific ligands.Sci Rep. 2022 May 20;12(1):8555. doi: 10.1038/s41598-022-12118-3. Sci Rep. 2022. PMID: 35595733 Free PMC article.
-
Folate receptor-positive circulating tumor cells as a novel diagnostic biomarker in non-small cell lung cancer.Transl Oncol. 2013 Dec 1;6(6):697-702. doi: 10.1593/tlo.13535. eCollection 2013 Dec 1. Transl Oncol. 2013. PMID: 24466372 Free PMC article.
-
Multiphoton microscopy and fluorescence lifetime imaging microscopy (FLIM) to monitor metastasis and the tumor microenvironment.Clin Exp Metastasis. 2009;26(4):357-70. doi: 10.1007/s10585-008-9204-0. Epub 2008 Sep 3. Clin Exp Metastasis. 2009. PMID: 18766302 Review.
-
Recent advances in nanotechnology-based detection and separation of circulating tumor cells.Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016 Mar-Apr;8(2):223-39. doi: 10.1002/wnan.1360. Epub 2015 Aug 21. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2016. PMID: 26296639 Free PMC article. Review.
References
-
- Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, Miller MC, Reuben JM, Doyle GV, Allard WJ, Terstappen LW, et al. N Engl J Med. 2004;351:781–791. - PubMed
-
- Cristofanilli M, Hayes DF, Budd GT, Ellis MJ, Stopeck A, Reuben JM, Doyle GV, Matera J, Allard WJ, Miller MC, et al. J Clin Oncol. 2005;23:1420–1430. - PubMed
-
- Allard WJ, Matera J, Miller MC, Repollet M, Connelly MC, Rao C, Tibbe AGJ, Uhr JW, Terstappen LW. Clin Cancer Res. 2004;10:6897–6904. - PubMed
-
- Molnar B, Ladanyi A, Tanko L, Sreter L, Tulassay Z. Clin Cancer Res. 2001;7:4080–4085. - PubMed
-
- Muller V, Stahmann N, Riethdorf S, Rau T, Zabel T, Goetz A, Janicke F, Pantel K. Clin Cancer Res. 2005;11:3678–3685. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases